NCT03792321View on ClinicalTrials.gov

"Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients (SETH2)"

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 10, 2014

Primary Completion Date

March 5, 2015

Study Completion Date

March 5, 2018

Conditions
Hypogonadism, MaleDiabetes Mellitus, Type 2Obesity
Interventions
DRUG

Testosterone Undecanoate

1000 mg i.m. every 10 weeks

DRUG

Placebo

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT03792321 - "Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients (SETH2)" | Biotech Hunter | Biotech Hunter